Correlation Between Lyell Immunopharma and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lyell Immunopharma and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyell Immunopharma and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyell Immunopharma and Foghorn Therapeutics, you can compare the effects of market volatilities on Lyell Immunopharma and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyell Immunopharma with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyell Immunopharma and Foghorn Therapeutics.
Diversification Opportunities for Lyell Immunopharma and Foghorn Therapeutics
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lyell and Foghorn is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Lyell Immunopharma and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Lyell Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyell Immunopharma are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Lyell Immunopharma i.e., Lyell Immunopharma and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Lyell Immunopharma and Foghorn Therapeutics
Given the investment horizon of 90 days Lyell Immunopharma is expected to under-perform the Foghorn Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Lyell Immunopharma is 1.06 times less risky than Foghorn Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Foghorn Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 810.00 in Foghorn Therapeutics on August 31, 2024 and sell it today you would lose (11.00) from holding Foghorn Therapeutics or give up 1.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyell Immunopharma vs. Foghorn Therapeutics
Performance |
| Timeline |
| Lyell Immunopharma |
| Foghorn Therapeutics |
Lyell Immunopharma and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyell Immunopharma and Foghorn Therapeutics
The main advantage of trading using opposite Lyell Immunopharma and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyell Immunopharma position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.| Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
| Foghorn Therapeutics vs. Cue Biopharma | Foghorn Therapeutics vs. Eliem Therapeutics | Foghorn Therapeutics vs. Inhibrx | Foghorn Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |